Axel Durieux

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9

PET Scans for Decision-Making in Metastatic Renal Cell Carcinoma: A Single-Institution Evaluation

M.S. Dilhuydy, Axel Durieux, Alexandre Pariente et al. · Oncology · 2006 · 29 citations

Medicine, Oncology, Radiology +17

Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France

Grégory Katz, Olivier Romano, Cyril Foa et al. · PLoS ONE · 2015 · 29 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Physicians' Attitudes Towards the Advice of a Guideline-Based Decision Support System: A Case Study With OncoDoc2 in the Management of Breast Cancer Patients

Jean‐Philippe Spano, Jean‐Pierre Lefranc, Isabelle Cojean-Zelek et al. · Studies in health technology and informatics · 2015 · 20 citations

Computing, Health Informatics, Oncology +17